Guardant Health director sells 116 shares after RSU vesting

Guardant Health director Tariq Musa reported transactions in company equity.

Rhea-AI Filing Summary

Guardant Health director Tariq Musa reported transactions in company equity. On July 15, 2026, he converted 250 Restricted Stock Units into 250 shares of common stock at no cash cost, leaving 1,999 RSUs outstanding. On July 16, he sold 116 shares of common stock in an open-market sale at $163.29 per share and held 11,182 shares afterward.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider Tariq Musa

Role Director

Sold 116 shs ($19K)

Approx. gross sale proceeds $19K

Approx. exercise cost $0.00

Type	Security	Shares	Price	Value
Sale	Common Stock	116	$163.29	$19K
Exercise	Restricted Stock Units F1, F2	250	$0.00	$0.00
Exercise	Common Stock	250	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 1,999 contracts (Direct); Common Stock — 11,182 shares (Direct)

Footnotes (2)

1. F1. The restricted stock unit award granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on March 15, 2024 and the remaining 75% vests monthly for the three-year period thereafter.
2. F2. Not applicable for Restricted Stock Units.

Key Figures

Common shares sold: 116 shares Sale price per share: $163.29 Shares acquired from RSU conversion: 250 shares +4 more

7 metrics

Common shares sold 116 shares Open-market sale of common stock on July 16, 2026

Sale price per share $163.29 Price per share for 116 common shares sold July 16, 2026

Shares acquired from RSU conversion 250 shares Common stock received from Restricted Stock Units on July 15, 2026

Common shares held after transactions 11,182 shares Total common stock directly owned following July 16, 2026 sale

Restricted Stock Units remaining 1,999 units RSUs outstanding after July 15, 2026 conversion

RSU grant date March 6, 2023 Grant date of Restricted Stock Unit award subject to four-year vesting

Initial RSU vesting date March 15, 2024 Date when 25% of the March 6, 2023 RSU award vested

Key Terms

Restricted Stock Units, open-market sale, derivative security, vests monthly

4 terms

Restricted Stock Units financial

"The restricted stock unit award granted on March 6, 2023 vests over a four-year period."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

open-market sale financial

"transaction_action: open-market sale of 116 shares of Common Stock."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

derivative security financial

"transaction_code_description: Exercise or conversion of derivative security."

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

vests monthly financial

"the remaining 75% vests monthly for the three-year period thereafter."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Tariq Musa report for Guardant Health (GH)?

Tariq Musa, a director of Guardant Health, reported both an RSU conversion and a stock sale. He converted 250 Restricted Stock Units into 250 common shares on July 15, 2026, then sold 116 common shares in an open-market transaction on July 16, 2026.

How many Guardant Health (GH) shares did Tariq Musa sell and at what price?

He sold 116 shares of Guardant Health common stock in an open-market sale. The reported sale price was $163.29 per share, providing a clear view of the transaction size and pricing relative to his remaining holdings.

How many Guardant Health (GH) shares does Tariq Musa hold after these transactions?

Following the July 16, 2026 sale, Tariq Musa directly holds 11,182 shares of Guardant Health common stock. This figure reflects his position after selling 116 shares and after receiving 250 shares from the earlier Restricted Stock Unit conversion.

What happened to Tariq Musa’s Restricted Stock Units in Guardant Health (GH)?

On July 15, 2026, 250 Restricted Stock Units were converted into 250 common shares at no cash exercise price. After this conversion, Musa still holds 1,999 Restricted Stock Units, representing additional potential future common stock upon vesting and settlement.

What is the vesting schedule for Tariq Musa’s March 6, 2023 RSU award at Guardant Health (GH)?

The March 6, 2023 RSU award vests over four years. 25% of the shares vested on March 15, 2024, and the remaining 75% vests monthly over the subsequent three-year period, creating ongoing incremental equity delivery over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/16/2026 - 04:56 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tariq Musa

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/15/2026		M		250	A	$0	11,298	D
Common Stock	07/16/2026		S		116	D	$163.29	11,182	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	07/15/2026		M			250	(1)	(2)	Common Stock	250	$0	1,999	D

Explanation of Responses:

1. The restricted stock unit award granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on March 15, 2024 and the remaining 75% vests monthly for the three-year period thereafter.

2. Not applicable for Restricted Stock Units.

Remarks:

	/s/ John G. Saia, as attorney-in-fact for Musa Tariq	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)